Methods for expression and purification of immunotoxins

Details for Australian Patent Application No. 2004262023 (hide)

Owner The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health

Inventors Neville, David M.; Liu, Yuan-Yi; Woo, Jung-Hee

Agent Griffith Hack

Pub. Number AU-B-2004262023

PCT Pub. Number WO2005/012495

Priority 60/491,923 01.08.03 US

Filing date 2 August 2004

Wipo publication date 10 February 2005

Acceptance publication date 10 March 2011

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/14 (2006.01) Micro-organisms, e.g. protozoa - Fungi

C12N 1/16 (2006.01) Micro-organisms, e.g. protozoa - Yeasts

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/012495 Priority application(s): WO2005/012495

10 March 2011 Application Accepted

  Published as AU-B-2004262023

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262024-Water-based drilling fluids using latex additives

2004262022-Accelerated vaccination